Language Fluency Deficits in Post-treatment Lyme Disease Syndrome

被引:0
|
作者
Gorlyn, Marianne [1 ,2 ,3 ]
Keilp, John G. [1 ,2 ]
Fallon, Brian A. [1 ]
机构
[1] Columbia Univ Vagelos Coll Phys & Surg, Dept Psychiat, Div Clin Therapeut, New York, NY 10032 USA
[2] Columbia Univ Vagelos Coll Phys & Surg, Dept Psychiat, Div Mol Imaging & Neuropathol, New York, NY 10032 USA
[3] Columbia Univ Vagelos Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA
关键词
Infectious diseases non-HIV; Fluency (verbal; nonverbal); SEMANTICS; BRAIN;
D O I
10.1093/arclin/acac095
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective Recent neurocognitive studies of patients with post-treatment Lyme disease syndrome (PTLDS) find consistent deficits in memory and processing speed. Language fluency deficits are observed as well but may be secondary to poor memory and slowing rather than an independent deficit. Method This study performed a secondary analysis of data presented previously, including individuals with PTLDS and comparison samples of healthy volunteers (HC) and patients with major depressive disorder (MDD), to determine if language fluency deficits could be accounted for by poor performance in these other neurocognitive domains. Results Basic verbal abilities, memory, and processing speed were all significantly associated with fluency performance. MDD patients' fluency deficits relative to HC were accounted for by these covariates. However, PTLDS patients' poorer fluency performance relative to both other groups was not. Conclusions Language fluency appears to be an independent area of neurocognitive deficit within the constellation of PTLDS symptoms.
引用
收藏
页码:650 / 654
页数:5
相关论文
共 50 条
  • [21] ASSESSING THE INCIDENCE AND TREATMENT OF POST-TREATMENT LYME DISEASE SYNDROME IN AN ADMINISTRATIVE CLAIMS DATABASE
    Montejano, L. B.
    VALUE IN HEALTH, 2014, 17 (03) : A267 - A267
  • [22] What Makes It Tick: Exploring the Mechanisms of Post-treatment Lyme Disease Syndrome
    Wester, Kate E.
    Nwokeabia, Bianca C.
    Hassan, Rehana
    Dunphy, Taylor
    Osondu, Michael
    Wonders, Carson
    Khaja, Misbahuddin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [23] FLAIR and magnetization transfer imaging of patients with post-treatment Lyme disease syndrome
    Morgen, K
    Martin, R
    Stone, RD
    Grafman, J
    Kadom, N
    McFarland, HF
    Marques, A
    NEUROLOGY, 2001, 57 (11) : 1980 - 1985
  • [24] Gene set predictor for post-treatment Lyme disease
    Clarke, J. B. Daniel
    Rebman, W. Alison
    Fan, Jinshui
    Soloski, J. Mark
    Aucott, N. John
    Ma'ayan, Avi
    CELL REPORTS MEDICINE, 2022, 3 (11)
  • [25] Invalidation by medical professionals in post-treatment Lyme disease
    Rebman, Alison W.
    Yang, Ting
    Aucott, John N.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [26] Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?
    Aucott, John N.
    Rebman, Alison W.
    Crowder, Lauren A.
    Kortte, Kathleen B.
    QUALITY OF LIFE RESEARCH, 2013, 22 (01) : 75 - 84
  • [27] Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?
    John N. Aucott
    Alison W. Rebman
    Lauren A. Crowder
    Kathleen B. Kortte
    Quality of Life Research, 2013, 22 : 75 - 84
  • [28] Treatment of post-treatment Lyme disease symptoms-a systematic review
    Dersch, Rick
    Torbahn, Gabriel
    Rauer, Sebastian
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
  • [29] Annexin A2 antibodies in post-treatment Lyme disease
    Miller, John B.
    Rebman, Alison W.
    de Flores, Marcia Daniela Villegas
    Wang, Hong
    Darrah, Erika
    Aucott, John N.
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2024, 11
  • [30] The Data as It Is, and the Nature of Neurocognitive Difficulties in Post-Treatment Lyme Disease
    Keilp, John G.
    Fallon, Brian A.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2018, 33 (08) : 1083 - 1085